Dosing can be tricky, too
In SURMOUNT-1, nausea occurred in 24.6% of participants on 5mg, 33.3% on 10mg, and 31.0% on 15mg
I discuss prognosis again in a later chapter
Several variables may influence whether stomach function returns after stopping GLP-1 medications: Duration and dosage: Longer exposure and higher doses may increase permanent damage likelihood Pre-existing vulnerabilities: Patients with borderline slow emptying, prior surgery, diabetes, or autoimmune conditions may experience irreversible damage Individual metabolic factors: Variations in semaglutide metabolism may explain different outcomes Timing of intervention: Immediate discontinuation upon symptoms may improve recovery prospects The pharmaceutical industrys failure to conduct long-term outcome studies has left patients and the medical community without guidance
The color also is variable depending on the source
It's the focused tanning compound: purely pigmentation, without the libido and appetite effects that come with Melanotan II